Exactech and MMI Team Up On Trial (Biloine Young @ OTW)
Exactech, which will soon be conducting a BiPhasic Cartilage Repair Implant Clinical Trial that has been approved by the FDA of Taiwan, has engaged Medical Metrics, Inc., (MMI) of Houston, Texas, to evaluate the medical images. The randomized study will be conducted in Taiwan to evaluate a novel cartilage repair treatment.
According to Berkshire Hathaway’s Business Wire, the biphasic implant is a two-phase scaffold that is intended to promote integration with subchondral bone and regeneration of hyaline-like cartilage. During the study, M...
